This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 Jan;4(1):1-8.

doi: 10.2165/00002512-199404010-00001.

Is the use of chemotherapy justified in non-small-cell lung cancer?

P Kelly¹, L Clancy

Affiliations

PMID: 8130379
DOI: 10.2165/00002512-199404010-00001

Review

Is the use of chemotherapy justified in non-small-cell lung cancer?

P Kelly et al. Drugs Aging. 1994 Jan.

. 1994 Jan;4(1):1-8.

doi: 10.2165/00002512-199404010-00001.

Authors

P Kelly¹, L Clancy

Affiliation

¹ Peamount Hospital, Newcastle, Dublin, Ireland.

PMID: 8130379
DOI: 10.2165/00002512-199404010-00001

No abstract available

PubMed Disclaimer

Similar articles

[Chemotherapy in non-small-cell lung carcinoma. More than just promises?].
Feliu J, Ordóñez A, Espinosa J. Feliu J, et al. Med Clin (Barc). 1994 Jun 11;103(2):72-5. Med Clin (Barc). 1994. PMID: 8051975 Review. Spanish. No abstract available.
Chemotherapy in stage III non-small cell lung cancer.
Eberhardt WE, Hepp R. Eberhardt WE, et al. Eur J Cancer. 2009 Sep;45 Suppl 1:126-36. doi: 10.1016/S0959-8049(09)70024-3. Eur J Cancer. 2009. PMID: 19775611 No abstract available.
[Advanced lung cancer: progress in individualized therapy].
Bischoff A. Bischoff A. MMW Fortschr Med. 2009 May 21;151(21):20. MMW Fortschr Med. 2009. PMID: 19537631 German. No abstract available.
[Role of chemotherapy in non-small cell lung carcinoma].
Giaccone G, Dingemans AM. Giaccone G, et al. Ned Tijdschr Geneeskd. 1996 May 25;140(21):1111-4. Ned Tijdschr Geneeskd. 1996. PMID: 8692336 Review. Dutch. No abstract available.
Systemic treatment of non-small-cell lung cancer.
Lal R, Enting D, Kristeleit H. Lal R, et al. Eur J Cancer. 2011 Sep;47 Suppl 3:S375-7. doi: 10.1016/S0959-8049(11)70209-X. Eur J Cancer. 2011. PMID: 21944021 Review. No abstract available.

See all similar articles

Cited by

Vinorelbine in advanced non-small cell lung cancer. A pharmacoeconomic review.
Coukell AJ, Noble S, Faulds D. Coukell AJ, et al. Pharmacoeconomics. 1999 Apr;15(4):405-17. doi: 10.2165/00019053-199915040-00008. Pharmacoeconomics. 1999. PMID: 10537959
The aged patient with lung cancer. Management recommendations.
Zagonel V, Tirelli U, Serraino D, Lo Re G, Merola MC, Mascarin M, Trovò MG, Carbone A, Monfardini S. Zagonel V, et al. Drugs Aging. 1994 Jan;4(1):34-46. doi: 10.2165/00002512-199404010-00004. Drugs Aging. 1994. PMID: 8130381 Review.
Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.
Noble S, Goa KL. Noble S, et al. Drugs. 1997 Sep;54(3):447-72. doi: 10.2165/00003495-199754030-00009. Drugs. 1997. PMID: 9279506 Review.

References

1. JAMA. 1987 Jul 24-31;258(4):516 - PubMed
1. Cancer. 1991 Jan 1;67(1 Suppl):250-3 - PubMed
1. Am J Clin Oncol. 1988 Oct;11(5):566-71 - PubMed
1. Cancer. 1989 Apr 1;63(7):1271-8 - PubMed
1. N Engl J Med. 1993 Apr 1;328(13):971-5 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information